Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Popular cities in California
With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.
Why choose California for clinical trials?
The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.
California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.
Common conditions studied in California
Clinical trials in California address a wide range of medical conditions, reflecting the state’s diverse healthcare landscape and research focus. These diverse areas of focus reflect California’s commitment to advancing medical science and improving health outcomes through rigorous and innovative clinical research.
Infectious Diseases
Given California's role in global health, clinical trials frequently focus on infectious diseases including HIV/AIDS, hepatitis, and emerging infections such as COVID-19. Research aims to develop new antiviral drugs, vaccines, and treatment strategies to combat these diseases.
Key research focuses include developing new vaccines and treatments for COVID-19, advancing antiretroviral drugs and potential cures for HIV/AIDS, and innovating influenza vaccines. The state is also addressing challenges in tuberculosis with more effective therapies and exploring novel approaches for hepatitis. Research on emerging infectious diseases, including zoonotic and vector-borne illnesses, is ongoing, alongside efforts to combat antimicrobial resistance and develop new antifungal agents.
Cancer
California is a major hub for oncology research, with numerous trials investigating treatments for various types of cancer, including breast cancer, lung cancer, prostate cancer, and leukemia.
In California, clinical trials for cancer research are exploring a broad array of innovative treatments and therapies, including immunotherapy, targeted therapy, gene therapy, hormone therapy, radiation therapy, precision medicine, and novel chemotherapy agents.
Cardiovascular diseases
Clinical trials in California frequently focus on cardiovascular conditions such as heart disease, hypertension, and stroke. Research often explores novel drugs, medical devices, and lifestyle interventions aimed at improving heart health and reducing the risk of cardiovascular events.
These trials also explore a range of innovative treatments and therapies designed to improve heart health and manage cardiovascular conditions. These include gene and cell therapies, innovative device therapies, advanced imaging and diagnostic tools, advanced surgical techniques, and personalized medicine.
Neurological Disorders
California research centers are heavily involved in studies on neurological disorders including Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS), and epilepsy. Trials often investigate new drug treatments, gene therapies, and innovative approaches to managing and potentially curing these conditions, as well as improving diagnosis, treatment, and overall quality of life for patients.
California is a leader in neurological research trials, thanks to its robust network of world-renowned research institutions, as well as its advanced technologies and facilities, collaborative research equipment, significant investment, and an innovative research focus.
Chronic respiratory diseases
California's trials also cover chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Studies often explore new inhaled therapies, biologics, and approaches to managing chronic respiratory symptoms and improving lung function.
Several prominent research centers in California are dedicated to studying and advancing treatments for chronic respiratory diseases. UCLA Health’s research center focuses on asthma and COPD, exploring novel treatments and management strategies, while Stanford Medicine conducts cutting-edge research on chronic respiratory diseases through its Division of Pulmonary, Allergy, and Critical Care Medicine.
Diabetes
With diabetes being a significant public health issue, clinical trials in California frequently target both Type 1 and Type 2 diabetes. Research often focuses on new medications, insulin delivery systems, and lifestyle interventions to improve glucose control and reduce diabetes-related complications.
With several different leading research institutions in California, each one is trialing new and innovative therapies for diabetes. These include biologic and targeted therapies, personalized medicine, inhaled medication, immunomodulatory therapies, allergen immunotherapy, and novel drug combinations.
Autoimmune disorders
Clinical trials in California investigate autoimmune conditions such as rheumatoid arthritis, lupus, and dermatological conditions like psoriasis. Research often includes testing the effectiveness of new immunosuppressive drugs, biologics, and therapies aimed at modulating the immune system to reduce disease activity and improve patient outcomes.
These research efforts in California aim to improve patient outcomes by providing more effective, targeted treatment options and enhancing the management of these challenging autoimmune conditions.
Mental health disorders
California’s leading research institutions and medical centers are at the forefront of studying and developing new treatments for a range of mental health conditions, including depression, anxiety, bipolar disorder, schizophrenia, and neurodegenerative diseases with psychiatric components.
Mental health clinical trials often explore novel psychiatric medications, psychotherapy approaches, and integrated treatment strategies to enhance mental health care. Ongoing studies for mental health disorders in California also encompass a wide range of innovative and cutting-edge research efforts, including psychedelic substances, neurostimulation, genetic and molecular research, digital health, and preventative strategies.
Rare diseases
California's research institutions are involved in trials for various rare and orphan diseases, including genetic disorders and metabolic conditions. These studies aim to develop specialized treatments and improve diagnostic methods for conditions with limited therapeutic options.
Rare disease studies often focus on genetic conditions and explore groundbreaking treatments, exploring conditions like cystic fibrosis, Duchenne muscular dystrophy, Huntington’s disease, rare cancers, and other rare disorders. Research efforts focus on gene editing, enzyme replacement therapies, and drug development, pushing forward groundbreaking treatments for these often overlooked diseases.
Local regulations and guidelines
In California, clinical trials are governed by a combination of federal and state regulations designed to ensure the safety, efficacy, and ethical conduct of research. Federal oversight is provided by the U.S. Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP), which set standards for trial protocols, informed consent, and protection of participants.
At state level, California also incorporates additional requirements through agencies such as the California Department of Public Health and the California Clinical Trials Program. Local Institutional Review Boards (IRBs) play an important role in reviewing and approving research proposals to ensure compliance with ethical standards and participant protection. California also requires compliance with the California Health and Safety Code and the California Business and Professions Code, which include provisions related to informed consent, data privacy, and management of clinical trial data.
Benefits of participating in clinical trials
Participating in a clinical trial offers several significant benefits, including access to cutting-edge treatments and therapies that are not yet available to the general public. Participants receive meticulous care from top healthcare professionals who provide expert monitoring and support throughout the study.
In addition, involvement in clinical trials supports essential medical research, potentially leading to groundbreaking advancements in treatment for future patients. By joining a trial, individuals not only get early access to innovative medical options but also play a vital role in advancing scientific knowledge and enhancing future healthcare outcomes.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial in California
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.